BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7493311)

  • 1. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha.
    Bresci G; Parisi G; Banti S; Capzia A
    J Viral Hepat; 1995; 2(3):155-8. PubMed ID: 7493311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial.
    Gaeta GB; Di Virgilio D; Russo G; Stornaiuolo G; Nicolella U; Colella F; Grimaldi M; Pasquale G; Giusti G
    J Viral Hepat; 1997 May; 4(3):209-14. PubMed ID: 9181530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon.
    Bresci G; Parisi G; Bertoni M; Scatena F; Capria A
    J Viral Hepat; 2000 Jan; 7(1):75-8. PubMed ID: 10718946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C.
    Bosch O; Tapia L; Quiroga JA; Carreño V
    J Hepatol; 1993 Feb; 17(2):146-9. PubMed ID: 8445228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group.
    Davis GL; Lindsay K; Albrecht J; Bodenheimer HC; Balart LA; Perrillo RP; Dienstag JL; Tamburro C; Schiff ER; Carey W
    J Viral Hepat; 1994; 1(1):55-63. PubMed ID: 8790560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
    Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
    Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha.
    Pardo M; Castillo I; Navas S; Carreño V
    J Med Virol; 1995 Apr; 45(4):439-44. PubMed ID: 7545214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C.
    Arase Y; Chayama K; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Kobayashi M; Kumada H
    Hepatol Res; 2001 Sep; 21(1):55-66. PubMed ID: 11470628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha.
    Chemello L; Cavalletto L; Noventa F; Bonetti P; Casarin C; Bernardinello E; Pontisso P; Donada C; Casarin P; Belussi F
    J Viral Hepat; 1995; 2(2):91-6. PubMed ID: 7493303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial with interferon alfa 2-b in chronic hepatitis C patients.
    El-Zayadi AR; Selim O; El-Haddad S; Ahdy A
    J Egypt Public Health Assoc; 1994; 69(5-6):335-45. PubMed ID: 17212003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.
    Yao GB; Ji YY; Xu DZ; Gao J; Wu XH; Zhang QB; Hu DC
    Hepatogastroenterology; 1999; 46(26):1059-64. PubMed ID: 10370667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis C with interferon-alpha: a preliminary report.
    Yu ML; Chuang WL; Chen SC; Lu SN; Wang JH; Lin ZY; Hsieh MY; Wang LY; Chang WY
    Kaohsiung J Med Sci; 1996 Oct; 12(10):581-9. PubMed ID: 8918079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.